Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ)
CNY 14.12
(1.22%)
CNY 14.12
(1.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 691.54 Million | 785.18 Million | 846.14 Million | 882.47 Million | 842.06 Million | 703.41 Million |
| Cost of Revenue | 311.34 Million | 319.29 Million | 399.92 Million | 458.3 Million | 307.08 Million | 230.76 Million |
| Gross Profit | 380.19 Million | 465.89 Million | 446.21 Million | 424.16 Million | 534.97 Million | 472.64 Million |
| Operating Expenses | 333.27 Million | 346.89 Million | 339.59 Million | 285.64 Million | 333.86 Million | 314.34 Million |
| Selling, General and Administrative Expenses | 220.65 Million | 254.07 Million | 263.71 Million | 237.64 Million | 301.59 Million | 286.9 Million |
| Research and Development Expenses | 90.39 Million | 58.82 Million | 41.72 Million | 36.47 Million | 25.55 Million | 15.21 Million |
| Other Expenses | -19.4 Million | 34 Million | 34.16 Million | 11.52 Million | 6.7 Million | 2.43 Million |
| Cost and Expenses | 645.71 Million | 666.19 Million | 739.52 Million | 743.95 Million | 640.94 Million | 545.11 Million |
| Operating Income | 45.82 Million | 108.83 Million | 103.31 Million | 137.43 Million | 198.26 Million | 158.47 Million |
| Interest Expense | 1.01 Million | 14.41 Million | 18.22 Million | 17.2 Million | 9.19 Million | 1.25 Million |
| Income Tax Expense | 10.09 Million | 9.84 Million | 11.63 Million | 17.86 Million | 28.24 Million | 23.53 Million |
| Earnings before Tax | 42.79 Million | 108.24 Million | 103.41 Million | 137.04 Million | 197.99 Million | 160.9 Million |
| Net Income | 32.69 Million | 98.4 Million | 91.78 Million | 119.18 Million | 169.74 Million | 137.37 Million |
| Earnings Per Share Basic | 0.08 | 0.24 | 0.23 | 0.30 | 0.42 | 0.34 |
| Earnings Per Share Diluted | 0.08 | 0.24 | 0.23 | 0.30 | 0.42 | 0.34 |
| Weighted Average Shares Outstanding | 417.61 Million | 403.11 Million | 400.5 Million | 400.51 Million | 400.06 Million | 400.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 417.61 Million | 403.11 Million | 401.13 Million | 400.89 Million | 400.06 Million | 400.03 Million |
| Gross Margin | 0.55 | 0.59 | 0.53 | 0.48 | 0.64 | 0.67 |
| EBIT Margin | 0.18 | 0.26 | 0.23 | 0.23 | 0.27 | 0.27 |
| Profit Margin | 0.05 | 0.13 | 0.11 | 0.14 | 0.20 | 0.20 |
| EBITDA | 125.84 Million | 200.48 Million | 192.95 Million | 202.21 Million | 230.94 Million | 182.97 Million |
| Earnings Before Tax Margin | 0.07 | 0.14 | 0.12 | 0.16 | 0.24 | 0.23 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 196.37 Million | 185.46 Million | 228.39 Million | 176.28 Million | 691.54 Million | 154.8 Million |
| Cost of Revenue | 83.91 Million | 93.38 Million | 89.84 Million | 88.69 Million | 311.34 Million | 68.2 Million |
| Gross Profit | 112.45 Million | 92.07 Million | 138.54 Million | 87.59 Million | 380.19 Million | 86.59 Million |
| Operating Expenses | 80.58 Million | 86.22 Million | 91.85 Million | 96.27 Million | 339.05 Million | 80.5 Million |
| Selling, General and Administrative Expenses | 123.96 Million | 74.63 Million | 80.77 Million | 25.72 Million | - | 80.75 Million |
| Research and Development Expenses | 13.14 Million | 11.25 Million | 12.64 Million | 28.71 Million | - | 20.48 Million |
| Other Expenses | -56.52 Million | -329.09 Thousand | 20.83 Thousand | -2.84 Million | -3.02 Million | -235.78 Thousand |
| Cost and Expenses | 164.5 Million | 179.61 Million | 181.7 Million | 184.96 Million | 650.4 Million | 148.7 Million |
| Operating Income | 31.41 Million | 5.85 Million | 48.04 Million | -5.87 Million | 45.82 Million | 4.55 Million |
| Interest Expense | 340.07 Thousand | 4338.70 | - | 28.44 Thousand | 945.35 Thousand | 279.12 Thousand |
| Income Tax Expense | 4.11 Million | 2.27 Million | 7.71 Million | 3.35 Million | 10.09 Million | 902.23 Thousand |
| Earnings before Tax | 31.47 Million | 11.62 Million | 48.06 Million | -8.71 Million | 42.79 Million | 4.31 Million |
| Net Income | 27.36 Million | 6.86 Million | 40.35 Million | -12.07 Million | 32.69 Million | 3.41 Million |
| Earnings Per Share Basic | 0.07 | 0.02 | 0.10 | -0.03 | - | 0.01 |
| Earnings Per Share Diluted | 0.07 | 0.02 | 0.10 | -0.03 | - | 0.01 |
| Weighted Average Shares Outstanding | 417.59 Million | 417.59 Million | 417.71 Million | 417.59 Million | 417.61 Million | 417.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 417.59 Million | 417.59 Million | 417.71 Million | 417.59 Million | 417.61 Million | 417.59 Million |
| Gross Margin | 0.57 | 0.50 | 0.61 | 0.50 | 0.55 | 0.56 |
| EBIT Margin | 0.16 | 0.15 | 0.22 | -0.07 | - | 0.03 |
| Profit Margin | 0.14 | 0.04 | 0.18 | -0.07 | 0.05 | 0.02 |
| EBITDA | 31.12 Million | 27.12 Million | 49.66 Million | -11.86 Million | - | 5.07 Million |
| Earnings Before Tax Margin | 0.16 | 0.03 | 0.21 | -0.03 | 0.07 | 0.03 |
MUX
IXC
1289
RCC
KHNGF
IMCC